Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial
Maveropepimut-S，一种基于DPX的免疫教育疗法，在复发性卵巢癌患者中显示出令人鼓舞且持久的临床获益，一项II期试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-2595
Dorigo, Oliver; Oza, Amit M; Pejovic, Tanja; Ghatage, Prafull; Ghamande, Sharad; Provencher, Diane; MacDonald, Lisa D; Torrey, Heather; Kaliaperumal, Valarmathy; Ebrahimizadeh, Walead; Hirsch, Heather A; Bramhecha, Yogesh; Villella, Jeannine; Fiset, Stephan
